Results 11 to 20 of about 16,893 (203)

Pemphigus Vulgaris Associated with Rheumatoid Arthritis in a Patient not Taking Penicillamine

open access: yesJournal of Dental Research, Dental Clinics, Dental Prospects, 2012
D-penicillamine is one of the disease-modifying anti-rheumatic drugs (DMARDs). Drug-induced pemphigus is not frequently associated with D-penicillamine, and to date, the number of reported cases is about a hundred. Most reports of Dpenicillamine-induced
Narges Gholizadeh   +2 more
doaj   +2 more sources

D-penicillamine induced degenerative dermopathy

open access: yesIndian Journal of Dermatology, 2015
D-penicillamine interferes with elastin and collagen metabolism and produces several cutaneous and multi-systemic side-effects. We present two cases of Wilson′s disease who on long-term penicillamine therapy developed drug-induced degenerative dermopathy
Sujay Khandpur   +4 more
doaj   +2 more sources

Validity of D-penicillamine in experimental cerebral vasospasm therapy

open access: yesInterdisciplinary Neurosurgery
Background: Cerebral vasospasm is a reversible vessel constriction following subarachnoid hemorrhage. Immunoreactive and inflammatory mechanisms induce long-term vasoconstriction and vessel dilatation inhibition.
Ersin Haciyakupoglu   +6 more
doaj   +2 more sources

D-Penicillamine-Induced Stevens–Johnson Syndrome in a Patient with Gold Cyanide Intoxication: A Case Report

open access: yesClinical, Cosmetic and Investigational Dermatology
Tanaporn Anuntrangsee, Kumutnart Chanprapaph, Wimolsiri Iamsumang Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Wimolsiri Iamsumang, Division of Dermatology,
Anuntrangsee T   +2 more
doaj   +1 more source

Synthesis and anti-intracellular Copper overload evaluation of Nanoconjugated D-penicillamine –Dendrimer in Wilson’s model cells

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2016
Background and Objective: Wilson’s disease (WD) is caused by mutation to the cooer-transporting gene ATP7B. Chelation therapy is the main protochol of treatment for patients with Wilson’s disease.
Fani N   +4 more
doaj   +1 more source

Therapeutic Reversal of Severe Neuropsychiatric Symptoms in Wilson's Disease: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Wilsons disease is an autosomal recessive genetic disorder of copper metabolism that results in copper accumulation in liver and other organs. Hepatic manifestation tends to occur earlier than the neurological manifestation. We present a case with psychiatric presentation.
Penjor T, Dorji S, Wangchuk S.
europepmc   +2 more sources

Effect of D-penicillamine on Vitamin B6 Activation of Aspartate Aminotransferase in Synaptosomes of the Developing Brain [PDF]

open access: yesJournal of Sciences, Islamic Republic of Iran, 1989
The activity of aspartate aminotransferase a vitamin B6 containing enzyme was measured in the laysed synaptosomes prepared from rat brain, during development. Administration of vitamin B6 increased the enzyme activity throughout development.
doaj   +1 more source

Penicillamine Nephropathy [PDF]

open access: yesNephron, 2008
8 patients who developed proteinuria whilst receiving penicillamine for rheumatoid arthritis have been studied. Light microscopy of renal biopsy specimens showed evidence of an extramembranous nephropathy in 6 cases, with epimembranous spikes infrequently described previously in association with penicillamine.
J H, Ross, F, McGinty, D G, Brewer
openaire   +2 more sources

STUDIES IN THE CHELATION OF D-PENICILLAMINE [PDF]

open access: yes, 1979
D-penicillamine is used in the treatment of Wilson’s disease but its precise mode of action in Inducing the urinary excretion of copper is not understood.
Prime, Diana M.
core   +3 more sources

Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. [PDF]

open access: yes, 1985
One hundred and eighty nine patients with primary biliary cirrhosis were entered into a double blind, placebo controlled randomised trial starting in January 1978 to assess the therapeutic value of d-penicillamine 1200 mg daily.
Tygstrup, Niels   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy